Buy Tagrisso (Osimertinib) Online

0 out of 5

  • DISEASE INDICATIONS: Lung Cancer
  • MANUFACTURER: AstraZeneca AB
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • Therapeutic Goods Administration (TGA)
  • Medsafe (NZ)
Tagrisso, with the generic name osimertinib, is a prescription medication used in the treatment of non-small cell lung cancer (NSCLC).

$5,720.00
Select optionsThis product has multiple variants. The options may be chosen on the product page